Yun Tang
About Yun Tang
Yun Tang is the VP, Head of Cell Therapy MSAT at National Resilience, Inc., with over 20 years of experience in the biotechnology and pharmaceutical industries.
Current Role at National Resilience, Inc.
Yun Tang serves as the Vice President and Head of Cell Therapy MSAT at National Resilience, Inc., a role he assumed in November 2021. Positioned in the United States, Yun leverages his vast experience in cell therapy manufacturing science and technology (MSAT) to drive innovation and operational excellence. His role underscores his leadership within the biotechnology field, focusing on advancing cell therapy solutions.
Previous Experience at Bristol-Myers Squibb
From 2019 to 2021, Yun Tang was the Head of Cell Therapy Development Engineering, Automation & Operations at Bristol-Myers Squibb in the Greater Seattle Area. During his two-year tenure, he led engineering and operational efforts for cell therapy development, focusing on streamlining processes and implementing automation to enhance production capabilities.
Leadership at JunoTherapeutics
Yun Tang held the position of Head of Cell Therapy Development Operations at JunoTherapeutics, a Celgene, Inc. company, from 2018 to 2019. In this role, also based in the Greater Seattle Area, he was responsible for overseeing cell therapy development operations, contributing to the company's mission to innovate in the cell therapy space.
Director of Analytical Operations at Genentech
Yun Tang worked at Genentech for 17 years, serving as the Director of Analytical Operations. This extensive period at Genentech provided him with deep expertise in analytical operations, crucial for ensuring the accurate and efficient development of biopharmaceutical products. His role involved managing analytical processes and upholding quality standards.
Educational Background
Yun Tang has a comprehensive educational background with degrees from multiple institutions. He holds a Master of Science in Bioengineering and Biomedical Engineering from the New Jersey Institute of Technology, and an MBA with a focus on Operations Management and Supervision from the University of Wisconsin-Eau Claire, achieved between 2011 and 2014. Additionally, he completed another MBA program in Operations Management in Healthcare from the same university.